Prostate Cancer - Results from #21260

It ain't what you do, it's the way you do it: Five golden rules for transforming prostate-specific antigen screening - Abstract February 11, 2014

Is "pelvic radiation disease" always the cause of bowel symptoms following prostate cancer intensity-modulated radiotherapy? - Abstract February 11, 2014

A different method of evaluation of the ERSPC trial confirms that prostate-specific antigen testing has a significant impact on prostate cancer mortality - Abstract February 11, 2014

Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer - Abstract February 10, 2014

Activity of cabazitaxel in castration-resistant prostate cancer progressing after docetaxel and next-generation endocrine agents - Abstract February 10, 2014

Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer - Abstract February 10, 2014

On the sensitivity of α/β prediction to dose calculation methodology in prostate brachytherapy - Abstract February 10, 2014

The impact of robot-assisted radical prostatectomy on the use and extent of pelvic lymph node dissection in the "post-dissemination" period - Abstract February 10, 2014

Target ablation-Image-guided therapy in prostate cancer - Abstract February 10, 2014

Decisional regret after robotic-assisted laparoscopic prostatectomy is higher in African American men - Abstract February 10, 2014

Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: An analysis of five European institutions - Abstract February 10, 2014

Bone metastases treated with radiopharmaceuticals - Abstract February 7, 2014

Challenges and Recommendations for Early Identification of Metastatic Disease in Prostate Cancer - Abstract February 7, 2014

Luteinizing hormone-releasing hormone antagonists for urinary obstruction in prostate cancer - Abstract February 7, 2014

Change in prostate volume during extreme hypo-fractionation analysed with MRI - Abstract February 7, 2014

A prostate biopsy strategy based on a new clinical nomogram reduces the number of biopsy cores required in high-risk patients - Abstract February 7, 2014

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium - Abstract February 7, 2014

Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions - Abstract February 7, 2014

The impact of gastrointestinal and genitourinary toxicity on health related quality of life among irradiated prostate cancer patients - Abstract February 7, 2014

A feasible and time-efficient adaptation of NeuroSAFE for da Vinci robot-assisted radical prostatectomy - Abstract February 7, 2014

Page 1064 of 1436